Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-24T12:43:22.278Z Has data issue: false hasContentIssue false
  • English
  • Français

USING APPROPRIATE COMPARISONS IN ECONOMIC EVALUATIONS

An Exercise in Belgium

Published online by Cambridge University Press:  01 January 1999

Olivier Van Tiggelen ,
Guy Storme ,
Koen Torfs  and
Dirk Van den Berge
Olivier Van Tiggelen
Affiliation:
Free University of Brussels (VUB)
Guy Storme
Affiliation:
Free University of Brussels (VUB)
Koen Torfs
Affiliation:
European Organisation for Research and Treatment of Cancer (EORTC)
Dirk Van den Berge
Affiliation:
Free University of Brussels (VUB)
Get access Rights & Permissions [Opens in a new window]

Abstract

This paper considers standard effective treatments for non-Hodgkin's lymphoma and early breast cancer in premenopausal women. The literature assesses the treatments' effectiveness, and expected charges for different treatments in the context of the Belgian Health Insurance System are compared. Ovariectomy in breast cancer (770 ECU) and conventional chemotherapy in non-Hodgkin (2,745 lymphoma ECU) prove equally effective and are less costly in comparison with chemotherapy (1,904 ECU) in breast cancer or chemotherapy and autologous bone marrow transplantation (19,262 ECU) in non-Hodgkin's lymphoma. Further unbiased insights in competitive treatments' costs and outcome could save money and enhance developments in cancer care.

Keywords

CostsEffectivenessNon-Hodgkin's LymphomaBreast Cancer
Type
RESEARCH NOTES
Information
International Journal of Technology Assessment in Health Care , Volume 15 , Issue 1 , January 1999 , pp. 243 - 263
Copyright
© 1999 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)